Net clinical benefit of patiromer for acute hyperkalemia: a post-hoc analysis of the reduce trial

Robert McArthur, W. Frank Peacock, Jeff Budden, Zubaid Rafique

Open source

DOI
10.1080/07853890.2025.2581912
Published
2025-11-03
Container
Annals of Medicine
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/07853890.2025.2581912,
  title = {Net clinical benefit of patiromer for acute hyperkalemia: a post-hoc analysis of the reduce trial},
  author = {Robert McArthur and W. Frank Peacock and Jeff Budden and Zubaid Rafique},
  year = {2025},
  journal = {Annals of Medicine},
  doi = {10.1080/07853890.2025.2581912},
  url = {https://doi.org/10.1080/07853890.2025.2581912}
}

RIS

TY  - JOUR
TI  - Net clinical benefit of patiromer for acute hyperkalemia: a post-hoc analysis of the reduce trial
AU  - Robert McArthur
AU  - W. Frank Peacock
AU  - Jeff Budden
AU  - Zubaid Rafique
PY  - 2025
JO  - Annals of Medicine
DO  - 10.1080/07853890.2025.2581912
UR  - https://doi.org/10.1080/07853890.2025.2581912
ER  - 

APA

McArthur, R., Peacock, W. F., Budden, J., & Rafique, Z. (2025). Net clinical benefit of patiromer for acute hyperkalemia: a post-hoc analysis of the reduce trial. Annals of Medicine. https://doi.org/10.1080/07853890.2025.2581912

Source records